
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
BUB3 CRISPR/Cas9 KO Plasmid (h) | sc-402439 | 20 µg | $397.00 | |||
BUB3 HDR Plasmid (h) | sc-402439-HDR | 20 µg | $445.00 |
BUB3 encodes a conserved spindle assembly checkpoint protein that binds BUB1 and BUBR1 (BUB1B) to promote mitotic checkpoint complex formation and restrain APC/C activity until proper kinetochore–microtubule attachment is achieved. Through this SAC signaling, BUB3 helps maintain chromosome bi-orientation and faithful segregation during mitosis, limiting aneuploidy and chromosomal instability. Disruption of BUB3-regulated checkpoint control perturbs mitotic timing and can compromise genome integrity, processes frequently implicated in proliferative pathologies. Human BUB3 is therefore widely studied in cell-cycle regulation, kinetochore biology, and stress responses to spindle poisons.
BUB3 CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the BUB3 gene in human cell lines. Each plasmid in the pool co-expresses a unique sgRNA, targeting a distinct site within the BUB3 locus, alongside the Streptococcus pyogenes Cas9 nuclease, and encodes GFP to enable fluorescent identification and enrichment of successfully transfected cells. This multi-guide strategy increases the likelihood of inducing frameshifts or deletions that produce a functional knockout, offering a more robust alternative to single-guide approaches. DSBs induced at multiple sites are resolved through non-homologous end joining (NHEJ) or, when used with the included HDR donor template, homology-directed repair (HDR) at a defined target site within the locus.
When used in conjunction with the RFP-expressing HDR donor, GFP and RFP fluorescence can be used together to distinguish transfected from edited cell populations, streamlining flow cytometry-based sorting and clone selection workflows.
For applications requiring confirmed, selectable knockout clones, BUB3 HDR Plasmid (h) includes an HDR donor construct containing a puromycin resistance cassette (PuroR) and a red fluorescent protein (RFP) reporter, flanked by homology arms specific to a defined BUB3 target site.
When co-transfected with BUB3 CRISPR/Cas9 KO Plasmid (h):
The HDR donor construct features loxP sites flanking the PuroR-RFP selection cassette to allow clean marker removal following clone confirmation. Transient expression of Cre recombinase via the included Cre Vector: sc-418923 excises the cassette, leaving a minimal residual loxP site within the BUB3 locus and eliminating potential confounding effects on downstream assays.
This two-step approach:
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.